GHK-Cu — the copper-peptide complex, explained
GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK) with divalent copper (Cu²⁺). It was discovered in 1973 by Loren Pickart as a naturally-occurring plasma factor that restored "young" behavior to aged liver tissue in culture, and it has accumulated 50+ years of published research since — predominantly in skin biology, wound healing, and more recently in gene expression analysis. GHK-Cu sits in a fundamentally different research category from the metabolic peptides (semaglutide, tirzepatide, retatrutide) and the recovery peptides (BPC-157, TB-500) — it is a copper-carrying signalling molecule, not a receptor agonist. This primer covers the molecule, the proposed mechanisms, the published literature, administration routes, and what researchers should know before working with it.
The molecule. GHK is a tripeptide with sequence Gly-His-Lys. Molecular weight of the free peptide is approximately 340.4 Da. The copper complex, GHK-Cu, forms when divalent copper binds the peptide via the imidazole nitrogen of histidine, the α-amino group of glycine, and the backbone amide — creating a 1:1 molar ratio complex that gives the compound its characteristic deep-blue color. Total MW of the 1:1 complex is approximately 403.9 Da. The copper is not a contaminant or a carrier — it is functionally integral to the molecule's activity.
The Pickart hypothesis and the 50-year arc. Pickart's 1973 observation — that a factor in young human plasma restored aged liver tissue behavior in culture — led to the identification of GHK as an endogenous human peptide that circulates at ~200 ng/mL in young adults and declines with age (~80 ng/mL by age 60). The hypothesis that has animated most subsequent research is that GHK-Cu is a "system restoration" signal: it shifts gene expression patterns in multiple tissue types toward a younger or pre-injury state. This is a broad claim, and the evidence supporting it has grown from initial fibroblast culture work to, most recently, large-scale gene expression analyses using the Connectivity Map (CMAP) database.
Published literature — primary sources. The most-cited modern review is Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987 (doi: 10.3390/ijms19071987). This review pulls together 50 years of literature and adds the CMAP-derived gene expression analysis showing GHK-Cu modulates approximately 4,000 genes in human cell lines, including consistent upregulation of DNA repair and antioxidant-response genes and downregulation of inflammatory and matrix-degrading genes. For the skin/wound-healing specific literature, Gruchlik A, Jurzak M, Chodurek E, Dzierżewicz Z. Effect of GLY-HIS-LYS and its copper complex on TGF-β secretion in normal human dermal fibroblasts. Acta Pol Pharm. 2014;71(6):959-963 is a useful entry point to the fibroblast-signalling literature.
Proposed mechanisms. The mechanistic story has four components: (1) copper delivery — GHK serves as a high-affinity chaperone that delivers Cu²⁺ to intracellular copper-dependent enzymes including superoxide dismutase (SOD), cytochrome c oxidase, and lysyl oxidase; (2) TGF-β pathway modulation — GHK-Cu has been shown to modulate TGF-β secretion in dermal fibroblasts, which is the basis for its collagen-synthesis effects; (3) metallothionein induction — GHK-Cu upregulates metallothioneins (MT1/2/3), which are implicated in antioxidant defense and metal-ion homeostasis; (4) direct gene expression effects — the CMAP data suggest GHK-Cu has signature effects on gene expression independent of its copper chaperone role. Which of these is dominant in any given application depends on the context.
Administration routes in the literature. GHK-Cu has been studied via topical application (creams, serums — the dominant mode in cosmetic research), subcutaneous injection (the dominant mode in animal wound-healing studies), intravenous (limited human studies on wound healing), and intranasal (emerging area for neurological research). Topical bioavailability is established but low — most topical studies use concentrations in the 0.1-1% range. For injection protocols, the published rodent literature uses doses in the 0.1-10 μg/kg range. Vivaprime's GHK-Cu pen format is designed for subcutaneous injection in a research context.
Photosensitivity and why the pen format matters. GHK-Cu is photosensitive — extended light exposure causes copper dissociation and degradation of the peptide component. Lyophilized GHK-Cu stored in opaque packaging is stable for years at 2–8 °C; reconstituted solutions in transparent vials exposed to light can degrade meaningfully within days. The pen format addresses this two ways: the cartridge is sealed in an amber-tinted housing, and the solvent system is stability-tested for the in-use window. Store the pen in its included amber carton between doses.
Why it's co-studied with other skin-research peptides. In dermatological research protocols, GHK-Cu is often paired with copper peptides with different binding motifs (e.g. the related AHK-Cu or GHK-Cu analogs with modified C-terminal residues) or with growth factors (EGF, FGF) to study combinatorial effects on fibroblast proliferation and collagen synthesis. These studies are outside Vivaprime's current catalog but are a useful context for the research literature.
What the COA should say. A batch-specific COA for GHK-Cu should include (1) identity confirmation of the peptide backbone by HPLC-MS against the theoretical mass of the free peptide (~340.4 Da) or the copper complex (~403.9 Da), (2) copper content verified by atomic absorption or ICP-MS — this is critical for GHK-Cu specifically because the copper:peptide molar ratio determines activity, (3) purity by reverse-phase HPLC-UV with the main peak integrated, (4) residual solvent profile per ICH Q3C, (5) endotoxin by LAL in EU/mg. The COA should explicitly state the copper:peptide molar ratio; a ratio significantly different from 1:1 indicates either excess free peptide (no biological activity) or free copper (potentially problematic).
Research-use only. Vivaprime supplies GHK-Cu as research reference material for qualified researchers engaged in in-vitro laboratory work. GHK-Cu is an ingredient in many cosmetic products but the material supplied here is not formulated or released as a cosmetic product. Nothing on this page constitutes a therapeutic, diagnostic, cosmetic, or consumption recommendation. Purchasers affirm the research-use agreement at checkout.